Patents by Inventor Anuradha Mehta

Anuradha Mehta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods And Agents For Screening For Compounds Capable Of Modulating Gene Expression
    Publication number: 20150253304
    Abstract: The invention relates to the fields of screening assays, compounds, and methods for altering gene expression and protein levels. In particular, the invention includes assays to screen for agents capable of modulating gene expression in a UTR-dependent manner and agents capable of modulating gene expression.
    Type: Application
    Filed: May 22, 2015
    Publication date: September 10, 2015
    Applicant: PTC Therapeutics, Inc.
    Inventors: Liangxian Cao, Nikolai Naryshkin, Charles Romfo, Matthew C. Pelligrini, Anuradha Mehta, Panayiota Trifillis, Christopher R. Trotta
  • Methods and agents for screening for compounds capable of modulating gene expression
    Patent number: 9068234
    Abstract: The invention relates to the fields of screening assays, compounds, and methods for altering gene expression and protein levels. In particular, the invention includes assays to screen for agents capable of modulating gene expression in a UTR-dependent manner and agents capable of modulating gene expression.
    Type: Grant
    Filed: July 21, 2004
    Date of Patent: June 30, 2015
    Assignee: PTC Therapeutics, Inc.
    Inventors: Liangxian Cao, Anuradha Mehta, Nikolai A. Naryshkin, Matthew C. Pellegrini, Charles M. Romfo, Panayiota Trifillis, Christopher R. Trotta
  • Methods and agents for screening for compounds capable of modulating her2 expression
    Publication number: 20070072186
    Abstract: The invention relates to the fields of screening assays and compounds and methods for altering protein expression and levels of protein. In particular, the invention includes assays to screen for agents capable of modulating expression of Her2 and agents capable of modulating Her2 expression.
    Type: Application
    Filed: November 17, 2004
    Publication date: March 29, 2007
    Inventors: Anuradha Mehta, Christopher Trotta
  • Methods and agents for screening for compounds capable of modulating gene expression
    Publication number: 20050048549
    Abstract: The invention relates to the fields of screening assays, compounds, and methods for altering gene expression and protein levels. In particular, the invention includes assays to screen for agents capable of modulating gene expression in a UTR-dependent manner and agents capable of modulating gene expression.
    Type: Application
    Filed: July 21, 2004
    Publication date: March 3, 2005
    Inventors: Liangxian Cao, Anuradha Mehta, Nikolai Naryshkin, Matthew Pellegrini, Charles Romfo, Panayiota Trifillis, Christopher Trotta
  • Oxalate decarboxylate
    Patent number: 5547870
    Abstract: The present invention relates, in general, to an enzyme that degrades oxalic acid. In particular, the invention relates to the enzyme oxalate decarboxylase and to a DNA sequence encoding same. The invention further relates to a recombinant molecule comprising the oxalate decarboxylase encoding sequence and to a host cell transformed therewith. In addition, the invention relates to a method of protecting a plant from the deleterious effects of oxalic acid and to a method of reducing the oxalic acid content of a plant.
    Type: Grant
    Filed: October 18, 1994
    Date of Patent: August 20, 1996
    Assignee: Zeneca Limited
    Inventors: Asis Datta, Anuradha Mehta, K. Natarajan